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Background: Our objective was to study the feasibility of detecting
chromosomal deletions at 3p22.1 and 10q22.3 by fluorescent in situ
hybridization (FISH) and to examine their distribution in different
areas of the airway in patients with non-small cell lung cancer.
Methods: Brush biopsies from the mainstem bronchus on the
normal side contralateral to the tumor (NBB) and mainstem bron-
chus on the tumor side (TBB) were obtained from 122 patients who
underwent surgical resection. Touch preparations from the tumor
(TTP), normal lung parenchyma, and bronchi adjacent to the tumor
were also obtained. Two FISH assays using probes complementary
to 3p22.1 and 10q22.3 were used to detect deletions.
Results: NBB showed a relatively low deletion rate of 3p22.1 and
10q22.3 compared with TTP (p  0.0001). TBB showed a signifi-
cantly higher rate of deletions compared with NBB but lower than
TTP from the tumor (p  0.05) for both 3p22.1 and 10q22.3. A
significantly higher deletion rate was seen at TTP compared with
normal lung parenchyma at both the 3p22.1 and 10 q22.3 (p 
0.0001). Correlations were seen between the deletion rates of TTP
and TBB at 3p22.1 (  0.61, p  0.0001) and between TTP and
bronchi adjacent to the tumor at 10q22.3 (  0.64, p  0.0001).
Conclusion: Deletions of the 3p22.1 and 10q22.3 regions can be
reliably detected by FISH. As one progresses from the contralateral
normal bronchus to the bronchus on the side of tumor and the tumor
itself, the percentage of chromosomal deletions increases in a
statistically significant fashion. This suggests that, FISH analysis of
bronchoscopic brushes may be useful for identifying patients at high
risk for developing non-small cell lung cancer.
Key Words: Lung, Cancer, Non-small cell, Screening, Fluorescent
in situ hybridization, Bronchial brushes.
(J Thorac Oncol. 2008;3: 979–984)
Lung cancer is estimated to affect 213,380 patients andresult in 160,390 deaths in the United States in 2007 alone
(www.lungusa.org), making it the most lethal cancer, both
among men and women. Although early stage lung cancer is
eminently curable by surgery,1 most lung cancer is detected at
an advanced stage. This makes the overall outlook of lung
cancer dismal. This underscores the importance of develop-
ing methods of early detection for lung cancer. Several
approaches to early detection have been evaluated. High
resolution computed tomography scanning is one such ap-
proach. Another approach is to use sputum cytology2 and
various modes of bronchoscopy including white light bron-
choscopy and autofluorescence bronchoscopy.3 These tech-
niques have their own limitations. Bronchoscopy has limited
utility in the detection of peripheral lesions (which are form-
ing an increasing proportion of non small cell lung cancer
[NSCLC]). Sputum cytology has a low sensitivity in the
detection of lung cancer. One of the ways that the sensitivity
of sputum cytology has been improved is to study genetic
changes in bronchial cells seen in sputum that predate mor-
phologic changes detected by cytology.4 Several methods
have been used to detect early changes, including chromo-
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somal changes. One of these ways is fluorescent in situ
hybridization (FISH) technology.5,6
FISH uses segments of DNA labeled with a fluorescent
dye that can be detected at prespecified wavelengths. These
segments of DNA are hybridized to cells on slides and
compared with their corresponding centromeric region to
detect gain or loss of the chromosomal segment in question.
This enables the detection of a few abnormal cells in a
background of predominantly normal cells, which is typically
found in sputum cytologic specimens. This method has been
found to be useful in bladder cancer. A similar set of probes has
been used in the detection of abnormal cells in sputum cytology
based on the detection of chromosomal gain in the 5p, 7p, and 8q
regions7 These probes have been shown to improve the sensi-
tivity of sputum cytology. We have developed in-house probes
for the detection of chromosomal deletions at the 3p22.1 and
10q22.3 regions. These regions have been previously shown to
be chromosomally deleted by CGH array data.8 In this study,
these probes have been used to measure the deletion rate of these
chromosomal regions in bronchoscopic brush biopsies. We
show that this technique is feasible and shows instructive data on
the distribution of these deletions.
PATIENTS AND METHODS
Patient Population and Specimen Collection
Patients presenting to the thoracic surgery clinic at our
institution for potential resection were consented for acqui-
sition of bronchoscopic brush biopsies according to an IRB
approved protocol. Patients were entered into the study only
if they were deemed resectable and did not receive any
preoperative radiation or chemotherapy. Biopsies were per-
formed at the time of their preoperative bronchoscopy imme-
diately before the proposed resection. Clinical and pathologic
data was extracted from the prospective thoracic surgery
database maintained in our institution. Brush biopsies were
obtained from bronchoscopically normal mainstem bronchus
both on the side of the lesion (TBB) and the opposite side (NBB).
Once the tumor was resected and sent for pathologic analysis,
touch preps were made from bronchus adjacent to the tumor
(TAB), from the tumor itself (TTP) and from normal lung
parenchyma away from the tumor (NTP), depending on the
amount of tissue remaining after clinical pathologic use (Figure 1).
Specimen Preparation
The brush biopsies were received in saline. Cytospins
were prepared for cytology and FISH analysis. The cytology
slides were fixed in Carnoy’s solution and stained with
Papanicolaou stain, whereas the air dried slides were stained
with Diff-Quik (Baxter Scientific, Deerfield, IL). The cyto-
logic features of all the specimens were assessed. Both the
cytospins and the touch imprints were fixed for FISH in
methanol and acetic acid at 3:1 ratio before labeling. FISH
was performed with two probe sets.
FISH Technique
Two probe sets were used. The first probe set included
centromeric 3 (CEP3; Vysis) and the locus specific probe
3p22.1, which was labeled in-house. The second probe set
consisted of centromeric 10 (CEP10; Vysis) and the locus
specific probe 10q22.3 which was also developed in-house.
These probes were mixed with blocking DNA, enriched in
repetitive sequences and hybridized to the specimens. Spec-
trum Green was used to label the locus specific probes while
the centromeric probes came labeled with Spectrum Orange.
The technique for making the probes has been previ-
ously described6,9. Briefly, DNA was labeled by a commer-
cial nick translation kit. A gel was run to confirm that the size
of the DNA fragments was 500 to 2000 base pairs. The probe
was then placed in a 65°C water bath for 15 minutes and then
stored at 20°C.
Slides were immersed in 2X standard sodium citrate
(SSC) for 3 minutes at 77°C and then in a protease solution
(50 mL of 1 X phosphate-buffered saline [PBS], pH 2.0, and
25 mg of protease). Protease digestion was then performed
(5–6 minutes for cytospins and7–8 minutes for touch prep-
arations). Slides were then washed in 1 X PBS for 5 minutes
and subsequently fixed in a 1% formaldehyde solution for 5
minutes. Later, the slides were again washed with 1 X PBS
for 5 minutes and dehydrated in sequential 70%, 85%, and
100% ethanol solutions. After a brief period of drying, the
probe mixture was applied to the target areas on each slide,
covered with a cover slip, and sealed with rubber cement. The
slides were then kept in a hybridization machine (Vysis) for
20 hours at 37°C. After the rubber cement and cover slips
were removed, the slides were washed in a 50% formamide
solution (pH 7.45) in 3 separate jars for 10 minutes each at
45°C. Next, the slides were washed in 2 X SSC for 10
minutes at 45°C and then in 2 X SSC/0.1% ethoxylated octyl
phenol (NP-40) for 10 minutes. The slides were then dried.
Slides were counterstained with 4 6-Diamidine-2-phenylin-
dole dihydrochloride (10 l per slide), cover slipped, and
FIGURE 1. Schematic showing the areas of biopsy. NBB,
brush biopsy of the mainstem bronchus on the side opposite
the tumor; TBB, brush biopsy of the mainstem bronchus on
the side of the tumor; TAB, touch prep of the bronchus ad-
jacent to the tumor; NTP, touch prep of normal lung paren-
chyma; TTP, touch prep of the tumor.
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viewed under a fluorescent microscope (Leica DWRXA or
Leica DMLB; Leica Microsystems, Inc., Buffalo, NY) with
the appropriate filters for the probes.
The hybridized slides were counted with the appropri-
ate filter sets for visualizing Spectrum Green or Spectrum
Orange and 4 6-Diamidine-2-phenylindole dihydrochloride
counterstain. The nuclei of individual cells that did not
overlap were chosen for analysis. Slides were analyzed only
if 80% of the cells were interpretable in the field of view and
the brightness of the signals was 2 on a scale of 0 to 3.
Each cell was scored individually for the number of green
(3p22.1 or 10q22.3) and orange signals (CEP3 or CEP10,
respectively) that were used as internal controls. Cells with
fewer green signals than orange signals were positive, reflect-
ing deletion. The ratio of green to orange signals was inter-
preted as the percentage of deleted cells. To avoid misinter-
pretation due to insufficient hybridization, cells were counted
only if at least one bright orange and one bright green signal
were present. Split signals were counted as one if the space
between them was less than the diameter of a single signal. A
control specimen was used for each batch. Figure 2 shows
representative slides of the FISH technique used. From the
NBB, TBB, TAB, and NTP sites, deletions were scored in
100 morphologically intact bronchial epithelial cells at each
site. In tumor touch preparations, at least 100 tumor cells
were evaluated for deletions of 3p22.1 and 10q22.3 relative to
the internal centromeric probes. The accuracy of manual
scoring was confirmed by a random sample check performed
independently by a second cytogenetic technologist. This
score showed a strong correlation with the first score.
Analysis of Data
Deletions rates at different locations were tabulated in
percentages. To compare the deletion rates at different sites,
these were normalized to their technical controls before
comparison. The Wilcoxon signed rank test was used for
comparison of deletion rates at different sites. Correlations of
FISH measurements between the brush biopsies (TBB and
TAB) and the tumor touch preps (TTP) were evaluated by
Spearman correlation coefficients. Kaplan-Meier curves were
plotted for estimating time to death distributions. The log-
rank test was used to compare the difference in survival and
recurrence free survival between the FISH measurement high
score and low score groups, defined by the median deletion
rate. All tests are two-sided, and p-values less than 0.05 are
considered statistically significant. Analyses were per-
formed using the SPSS software version 13.0 (SPSS Inc.,
Chicago, IL).
RESULTS
Table 1 shows the demographic and clinical data that
describes this cohort of 122 patients included in the study.
The high percentage of women (52.5%) and adenocarcino-
matous histology (56.5%) is reflective of changing epidemi-
ologic trends in NSCLC. Very few of these patients have well
differentiated tumors (9.8%) and most patients are in the
earlier stages of the disease, as would be expected in a patient
group deemed resectable without neoadjuvant therapy.
Table 2 demonstrates the success rate of data acquisi-
tion at different locations. Although a high percentage of the
bronchial brushes could be analyzed successfully with FISH,
lower numbers of tumor and normal lung parenchyma could
FIGURE 2. Sample slides of the FISH analysis.
Orange signals are centromeric signals. Green
signals indicate 3p22.1 and 10q22.3 probes.
The cells with fewer green signals than orange
signals show cells that have deletions at either
the 3p22.1 (A) and 10q22.3 (B) loci.
TABLE 1. Clinical Characteristics of the Study Population









Squamous cell cancer 37 (30.3%)
Adenosquamous 3 (2.4%)
NSCLC (not specified) 7 (5.8%)
Other neoplasm 6 (4.8%)
Grade
Well differentiated 12 (9.8%)
Moderately differentiated 52 (42.6%)
Poorly/undifferentiated 49 (40.2%)
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be analyzed. A large part of this difference is attributable to
the sequence of specimen acquisition. Although bronchial
brushes were obtained on all patients first, a subset of these
patients underwent mediastinoscopy before surgical resec-
tion. If N2 or N3 nodes were positive at mediastinoscopy,
surgical resection was abandoned at the time, in keeping with
current practice at our institution. Specimens at TTP, NTP,
and TAB could therefore not be obtained from these patients.
Furthermore, some patients did not have an area suitable for
obtaining TAB specimens after clinical pathologic use, fur-
ther limiting the specimens available from this area. The
mean deletion rate at different locations for both 3p22.1 and
10q22.3 are also tabulated here. The highest deletion rate is
obtained from TTP at both loci. The next highest deletion rate
is obtained from bronchi adjacent to the tumor (TAB) or on
the same side (TBB). The lowest deletion rate is from areas
farthest away from the tumor which include normal lung
parenchyma (NTP) and mainstem bronchi on the nontumor
side (NBB) (Figure 3).
The deletion rate at different areas was compared with
the deletion rate at TTP using the Wilcoxon signed rank test.
The deletion rate at TTP was statistically significantly higher
than each of the other areas. There is also a statistically
significant difference in the deletion rate between the main-
stem bronchi on the tumor side and the nontumor side (TBB
and NBB). This holds true at both loci- 3p22.1 and 10q22.3.
Correlations between areas with a low deletion rate and
TTP were also determined. A strong statistically significant
correlation is demonstrated between the deletion rate at TBB
and the deletion rate at TTP at the 3p22.1 locus (Figure 4A;
spearman correlation coefficient  0.61). A similar statisti-
cally significant correlation is seen between the deletion rate
at TAB and the deletion rate at TTP at the 10q22.3 locus
(Figure 4B; spearman correlation coefficient  0.64). The
deletion rate of 3p22.1 at different locations was not predic-
tive of survival (data not shown). The median deletion rate at
10q22.3 both at TBB and TTP separated two groups that
demonstrated differing survival trends. This difference was
not statistically significant (Figure 5).
DISCUSSION
Early detection of lung cancer is of paramount impor-
tance due to the vast gap between the overall survival of
patients diagnosed with lung cancer and the survival of
patients with early lung cancer.10 Improvement in imaging
has renewed interest in image based screening and early
diagnostic efforts11 after earlier studies using chest radio-
graph screening were negative, presumably due to low sen-
FIGURE 3. The deletion rate at 3p22.1 and 10q22.3 in-
creases systematically as one progresses from tissue away
from the tumor towards the tumor itself. The deletion rate is
significantly greater in brush biopsies from mainstem bron-
chi on the tumor side (TBB) compared with the normal side
(NBB) (p  0.05). Similarly, the deletion rate at the tumor
itself (TTP) is significantly greater than TBB itself (p  0.05).
TABLE 2. Normalized Deletion Rate Detected by FISH in Different Regions of the Airway
3p22.1 N % Mean Deletion Rate  SE 10q22.3 N % Mean Deletion Rate  SE
3p22.1NBB 119 97.5 1.14  0.12 10q22.3NBB 119 97.5 0.53  0.06
3p22.1TBB 120 98.4 2.80  0.26 10q22.3TBB 119 97.5 1.61  0.09
3p22.1TAB 70 57.4 1.93  0.2 10q22.3TAB 69 56.6 1.76  0.15
3p22.1NTP 95 77.9 1.46  0.14 10q22.3NTP 93 76.2 0.88  0.09
3p22.1TTP 96 78.7 7.83  0.59 10q22.3TTP 96 78 4.76  0.34
FIGURE 4. A, 3p22.1 deletions at TBB correlate
with 3p22.1 deletions at TTP. Spearman coeff 
0.61, p  0.00001. B, 10q22.3 deletions at TAB
correlate with 10q22.3 deletions at TTP. Spear-
man coeff  0.64, p  0.00001.
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sitivity of the screening test.12 Similarly, methodological
improvement in the detection of chromosomal alterations in
sputum and bronchoscopic specimens has led to a renewed
interest in their use in the screening of lung cancer. Sputum
and bronchoscopic cytologic analysis has been limited by low
sensitivity. Fluorescent in situ hybridization increases the
sensitivity of cytologic analysis13 as this technique is better at
the detection of a small number of abnormal cells in a
background of normal cells.
A number of molecular changes have been described in
lung cancer. These include both loss of tumor suppressor
genes and activation of oncogenes.14,15 The 3p region is
presumed to be the site of several tumor suppressor genes
including FHIT, RASSF1A, and FUS1.16–18 It is one of the
earliest genetic losses in lung tumorigenesis. Therefore, using
a probe in this region is a logical choice for early detection.
The 10q22.3 region that is used as a probe in our study
includes the gene encoding the surfactant associated protein
A (SP-A). Pulmonary surfactant is important for normal lung
physiology and alterations in surfactant have been associated
with a number of lung diseases in children and adults. Of the
4 surfactant proteins, SP-A is the most abundant. The SP-A
gene locus consists of 2 homologous genes, each about 4.5 kb
in length separated by an 59 kb area.19 Alterations in SP-A
have been looked at using various techniques including re-
verse transcription-polymerase chain reaction, immunohisto-
chemistry, immunoblot analysis, and enzyme-linked immu-
nosorbent assay, with inconsistent results.20,21 In a cDNA
microarray analysis, we have shown this area to be one of the
more commonly deleted regions in lung cancer.8 Loss of this
region has also been demonstrated to portend a poorer prog-
nosis in patients with early stage lung cancer.22
A number of previous studies have used FISH detected
chromosomal gain but not loss to detect abnormal cells to
improve detection.5,7,13 A pilot study performed by our group
demonstrated the utility of FISH detected chromosomal loss
in the diagnosis of lung cancer.9 Here, we present results of
FISH detected deletions at the 3p22.1 and 10q22.3 locus in a
larger cohort of patients.
From the data presented, several conclusions can be
reached. The first is that FISH analysis with these probes is
technically feasible and reproducible enough for routine clin-
ical application. Good quality results can be obtained from
minimally invasive bronchoscopic methods like bronchial
brushes. The second conclusion is that there is a field effect
that can be demonstrated in a quantifiable fashion. The
pattern of this effect is intuitive, with the greatest deletion
rate being seen in tissue closest to the tumor and the lowest
deletion rate seen in tissue farthest away from the tumor. This
pattern is easily recognized when comparing the deletion rate
between the mainstem bronchus on the normal side (NBB)
and the tumor side (TBB), raising the possibility of utilizing
this data in the early detection of lesions. Of note, it is not
necessary for the tumor to have squamous histology or be a
central tumor to exhibit these changes. The strong correlation
of deletion rates between the bronchoscopic brushes and the
TTP not only increases the biologic validity of the data, but
also raises the possibility of using the deletion rates in
bronchoscopic specimens in lieu of TTP. This is particularly
important given the trend in survival shown by patients with
low deletion rates compared with patients with high deletion
rates at TBB and TTP. This suggests that we can potentially
use bronchoscopically acquired deletion rates for prognosti-
cation. The difference in survival in these groups corresponds
well with earlier published data of the ability of SP-A
expression to separate out patients with a good prognosis
from patients with a bad prognosis.22 This data also raises the
possibility of studying these deletions in sputum samples and
this has been a focus of further investigation by our group.23
CONCLUSION
Chromosomal deletions of the 3p22.1 and 10q22.3
regions can be reliably detected by FISH in brush biopsies
and touch preparations. As one progresses from the contralat-
eral normal bronchus to the bronchus on the side of tumor and
the tumor itself, the percentage of chromosomal deletions
increases in a statistically significant fashion. This suggests
FIGURE 5. Survival curves for patients
separated by median deletion rate at the
10 q locus at (A) TTP (p  0.176) (B) TBB
(p  0.153).
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that FISH analysis of bronchoscopic brushes may be useful
for identifying patients at high risk for developing NSCLC.
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